The technology will allow surgeons to rely less on a fallible mental construction of the resection plane, thereby reducing the risk of human error affecting the procedure.
Damage to these glands can cause hypoparathyroidism, a condition that can lead to low levels of calcium and elevated levels of phosphorus in the blood.
This project will be the first to apply drug conjugates in the field of obstetrics.
The goal of the wearable technology is to improve behavioral assessment of children with intellectual and developmental disabilities by predicting the precursors of problem behaviors and using that information to adjust therapeutic approaches.
A research endeavor that seeks to develop a new cancer immunotherapy utilizing nanobody delivery and targeted heating of tumors has received funding from the Waddell Walker Hancock Cancer Discovery Fund.
Investigators received a $3.2 million grant to develop novel brain network-based measures to guide surgical decisions and improve outcomes in the field of epilepsy surgery. The project builds upon work recently published by VUMC investigators in the journal Brain.